Waldron »

Tscan Therapeutics shares owned by Waldron

Quarter-by-quarter ownership of Tscan Therapeutics (TCRX) shares owned by Waldron from 13F filings

Historical chart of Waldron investment in Tscan Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tscan Therapeutics held by Waldron consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tscan Therapeutics by Waldron

Quarter filed Position value Share count Share price at filing
2023-12-31 $58k 10k 5.80
2023-09-30 $25k 10k 2.50
2023-06-30 $25k 10k 2.50
2023-03-31 $21k 10k 2.10

More positions owned by Waldron

iShares Russell 1000 Growth Index (IWF)
Ishares Core Intl Stock Etf core (IXUS)
Vanguard Value ETF (VTV)
iShares Russell 1000 Value Index (IWD)
Vanguard Growth ETF (VUG)
Vanguard Mun Bd Fd Inc tax-exempt bd (VTEB)
Invesco Russell 1000 Dynamic Multifactor Etf etf (OMFL)
Spdr S&p 500 Etf (SPY)
Vanguard Scottsdale Fds vng rus1000grw (VONG)
iShares Russell 2000 Value Index (IWN)
Vanguard High Dividend Yield ETF (VYM)
Apple (AAPL)
iShares S&P Global Infrastructure Index (IGF)
iShares S&P Natl AMTFr Mncpl Bd (MUB)
Vanguard Small-Cap Value ETF (VBR)

View all positions for Waldron

Top funds holding Tscan Therapeutics

Lynx1 Capital Management
EcoR1 Capital
BVF
Baker Bros. Advisors
Propel Bio Management
Vanguard Group
Deer Management
Alphabet
Simplify Asset Management
Standard Life Aberdeen
Stifel Financial
Marshall Wace
Millennium Management
NewEdge Wealth
Jane Street

View all funds holding Tscan Therapeutics